vs
Amarin Corp plc（AMRN）与FIDELITY D & D BANCORP INC（FDBC）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是FIDELITY D & D BANCORP INC的1.8倍（$45.1M vs $24.4M），FIDELITY D & D BANCORP INC净利率更高（32.5% vs -23.3%，领先55.8%），FIDELITY D & D BANCORP INC同比增速更快（15.0% vs 7.0%），过去两年FIDELITY D & D BANCORP INC的营收复合增速更高（11.8% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Fidelity D & D Bancorp Inc是一家总部位于美国的地区性银行控股公司，主要在宾夕法尼亚州东北部开展业务，为个人消费者、小微企业及当地社区客户提供存款账户、消费及商业贷款、抵押贷款、财富管理等综合零售及商业银行服务。
AMRN vs FDBC — 直观对比
营收规模更大
AMRN
是对方的1.8倍
$24.4M
营收增速更快
FDBC
高出8.0%
7.0%
净利率更高
FDBC
高出55.8%
-23.3%
两年增速更快
FDBC
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $24.4M |
| 净利润 | $-10.5M | $7.9M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 37.7% |
| 净利率 | -23.3% | 32.5% |
| 营收同比 | 7.0% | 15.0% |
| 净利润同比 | 33.0% | 36.1% |
| 每股收益（稀释后） | — | $1.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNFDBC
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $24.4M | ||
| Q3 25 | $49.7M | $23.5M | ||
| Q2 25 | $72.7M | $23.3M | ||
| Q1 25 | $42.0M | $22.0M | ||
| Q4 24 | $62.3M | $21.2M | ||
| Q3 24 | $42.3M | $20.4M | ||
| Q2 24 | $67.5M | $19.7M |
净利润AMRNFDBC
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $7.9M | ||
| Q3 25 | $-7.7M | $7.3M | ||
| Q2 25 | $-14.1M | $6.9M | ||
| Q1 25 | $-15.7M | $6.0M | ||
| Q4 24 | $-48.6M | $5.8M | ||
| Q3 24 | $-25.1M | $5.0M | ||
| Q2 24 | $1.5M | $4.9M |
毛利率AMRNFDBC
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNFDBC
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 37.7% | ||
| Q3 25 | -22.4% | 36.5% | ||
| Q2 25 | -22.0% | 35.5% | ||
| Q1 25 | -39.9% | 32.2% | ||
| Q4 24 | -84.3% | 31.4% | ||
| Q3 24 | -59.5% | 28.2% | ||
| Q2 24 | -0.8% | 28.9% |
净利率AMRNFDBC
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 32.5% | ||
| Q3 25 | -15.6% | 31.2% | ||
| Q2 25 | -19.4% | 29.7% | ||
| Q1 25 | -37.4% | 27.2% | ||
| Q4 24 | -78.0% | 27.5% | ||
| Q3 24 | -59.4% | 24.3% | ||
| Q2 24 | 2.3% | 25.0% |
每股收益（稀释后）AMRNFDBC
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $1.29 | ||
| Q3 25 | $-0.02 | $1.27 | ||
| Q2 25 | $-0.03 | $1.27 | ||
| Q1 25 | $-0.04 | $1.03 | ||
| Q4 24 | $-0.12 | $1.00 | ||
| Q3 24 | $-0.06 | $0.86 | ||
| Q2 24 | $0.00 | $0.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $148.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $238.9M |
| 总资产 | $645.8M | $2.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNFDBC
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $148.1M | ||
| Q3 25 | $286.6M | $142.2M | ||
| Q2 25 | $298.7M | $165.5M | ||
| Q1 25 | $281.8M | $211.2M | ||
| Q4 24 | $294.2M | $83.4M | ||
| Q3 24 | $305.7M | $120.2M | ||
| Q2 24 | $306.7M | $78.1M |
股东权益AMRNFDBC
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $238.9M | ||
| Q3 25 | $458.9M | $229.2M | ||
| Q2 25 | $464.9M | $217.9M | ||
| Q1 25 | $473.7M | $211.7M | ||
| Q4 24 | $486.2M | $204.0M | ||
| Q3 24 | $531.4M | $207.3M | ||
| Q2 24 | $551.9M | $195.7M |
总资产AMRNFDBC
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $2.7B | ||
| Q3 25 | $659.8M | $2.7B | ||
| Q2 25 | $670.1M | $2.7B | ||
| Q1 25 | $655.7M | $2.7B | ||
| Q4 24 | $685.3M | $2.6B | ||
| Q3 24 | $750.6M | $2.6B | ||
| Q2 24 | $799.9M | $2.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $42.4M |
| 自由现金流经营现金流 - 资本支出 | — | $24.8M |
| 自由现金流率自由现金流/营收 | — | 101.7% |
| 资本支出强度资本支出/营收 | — | 71.9% |
| 现金转化率经营现金流/净利润 | — | 5.34× |
| 过去12个月自由现金流最近4个季度 | — | $45.4M |
8季度趋势，按日历期对齐
经营现金流AMRNFDBC
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $42.4M | ||
| Q3 25 | $-12.7M | $8.4M | ||
| Q2 25 | $16.6M | $12.6M | ||
| Q1 25 | $-12.5M | $11.7M | ||
| Q4 24 | $-13.3M | $29.6M | ||
| Q3 24 | $-2.4M | $9.1M | ||
| Q2 24 | $-2.7M | $8.7M |
自由现金流AMRNFDBC
| Q1 26 | — | — | ||
| Q4 25 | — | $24.8M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | — | $6.9M | ||
| Q1 25 | — | $11.5M | ||
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $7.2M |
自由现金流率AMRNFDBC
| Q1 26 | — | — | ||
| Q4 25 | — | 101.7% | ||
| Q3 25 | — | 9.3% | ||
| Q2 25 | — | 29.6% | ||
| Q1 25 | — | 52.3% | ||
| Q4 24 | — | 117.3% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | — | 36.6% |
资本支出强度AMRNFDBC
| Q1 26 | — | — | ||
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 26.5% | ||
| Q2 25 | — | 24.4% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 22.0% | ||
| Q3 24 | — | 6.3% | ||
| Q2 24 | — | 7.5% |
现金转化率AMRNFDBC
| Q1 26 | — | — | ||
| Q4 25 | — | 5.34× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.82× | ||
| Q1 25 | — | 1.95× | ||
| Q4 24 | — | 5.07× | ||
| Q3 24 | — | 1.83× | ||
| Q2 24 | -1.81× | 1.76× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
FDBC
暂无分部数据
